JOURNAL OF PEDIATRIC INFECTION, vol.6, no.1, pp.1-5, 2012 (ESCI, Scopus, TRDizin)
Objective: The aim of this multicentric prospective study was to evaluate the efficacy of a new bioequivalent formulation of oseltamivir for the treatment of influenza A, influenza B and H1N1 during the 2010-2011 influenza season.